Gailani D, Broze GJ Jr (1991) Factor XI activation in a revised model of blood coagulation. Science 253(5022):909–912. https://doi.org/10.1126/science.1652157

Article  CAS  PubMed  Google Scholar 

Cheng Q, Tucker EI, Pine MS, Sisler I, Matafonov A, Sun MF, White-Adams TC, Smith SA, Hanson SR, McCarty OJ, Renné T, Gruber A, Gailani D (2010) A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood 116(19):3981–3989. https://doi.org/10.1182/blood-2010-02-270918

Article  CAS  PubMed Central  PubMed  Google Scholar 

Bouma BN, Griffin JH (1977) Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII. J Biol Chem 252(18):6432–6437

Article  CAS  PubMed  Google Scholar 

McMullen BA, Fujikawa K, Davie EW (1991) Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry 30(8):2056–2060. https://doi.org/10.1021/bi00222a008

Article  CAS  PubMed  Google Scholar 

Walsh PN, Sinha D, Koshy A, Seaman FS, Bradford H (1986) Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface. Blood 68(1):225–230

Article  CAS  PubMed  Google Scholar 

Doolittle RF (2009) Step-by-step evolution of vertebrate blood coagulation. Cold Spring Harb Symp Quant Biol 74:35–40. https://doi.org/10.1101/sqb.2009.74.001

Article  CAS  PubMed  Google Scholar 

Podmore A, Smith M, Savidge G, Alhaq A (2004) Real-time quantitative PCR analysis of factor XI mRNA variants in human platelets. J Thromb Haemost 2(10):1713–1719. https://doi.org/10.1111/j.1538-7836.2004.00924.x

Article  CAS  PubMed  Google Scholar 

Zhang X, Lewandowska M, Aldridge M, Iglay K, Wolford E, Shapiro A (2023) Global epidemiology of factor XI deficiency: a targeted review of the literature and foundation reports. Haemophilia 29(2):423–434. https://doi.org/10.1111/hae.14687

Article  CAS  PubMed  Google Scholar 

Maas C, Renné T (2018) Coagulation factor XII in thrombosis and inflammation. Blood 131(17):1903–1909. https://doi.org/10.1182/blood-2017-04-569111

Article  CAS  PubMed  Google Scholar 

Gruber A, Hanson SR (2003) Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. Blood 102(3):953–955. https://doi.org/10.1182/blood-2003-01-0324

Article  CAS  PubMed  Google Scholar 

Puy C, Tucker EI, Matafonov A, Cheng Q, Zientek KD, Gailani D, Gruber A, McCarty OJ (2015) Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor. Blood 125(9):1488–1496. https://doi.org/10.1182/blood-2014-10-604587

Article  CAS  PubMed Central  PubMed  Google Scholar 

Baglia FA, Badellino KO, Li CQ, López JA, Walsh PN (2007) Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 282(39):29067. https://doi.org/10.1016/s0021-9258(20)58639-0

Article  PubMed  Google Scholar 

Nieuwland R, Gardiner C, Dignat-George F, Mullier F, Mackman N, Woodhams B, Thaler J (2019) Toward standardization of assays measuring extracellular vesicle-associated tissue factor activity. J Thromb Haemost 17(8):1261–1264. https://doi.org/10.1111/jth.14481

Article  PubMed Central  PubMed  Google Scholar 

Greengard JS, Heeb MJ, Ersdal E, Walsh PN, Griffin JH (1986) Binding of coagulation factor XI to washed human platelets. Biochemistry 25(13):3884–3890. https://doi.org/10.1021/bi00361a022

Article  CAS  PubMed  Google Scholar 

Miller TN, Sinha D, Baird TR, Walsh PN (2007) A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets. Biochemistry 46(50):14450–14460. https://doi.org/10.1021/bi701310x

Article  CAS  PubMed  Google Scholar 

Fogelson AL, Hussain YH, Leiderman K (2012) Blood clot formation under flow: the importance of factor XI depends strongly on platelet count. Biophys J 102(1):10–18. https://doi.org/10.1016/j.bpj.2011.10.048

Article  CAS  PubMed Central  PubMed  Google Scholar 

Humphreys SJ, Whyte CS, Mutch NJ (2023) “Super” SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions. Front Cardiovasc Med 10:1146833. https://doi.org/10.3389/fcvm.2023.1146833

Article  CAS  PubMed Central  PubMed  Google Scholar 

Drake TA, Morrissey JH, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134(5):1087–1097

CAS  PubMed Central  PubMed  Google Scholar 

Mackman N (2004) Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24(6):1015–1022. https://doi.org/10.1161/01.Atv.0000130465.23430.74

Article  CAS  PubMed  Google Scholar 

Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U, Koyama T, Niepmann M, Trusheim H, Engelmann B, Preissner KT (2005) Extracellular RNA is a natural cofactor for the (auto-)activation of Factor VII-activating protease (FSAP). Biochem J 385(Pt 3):831–838. https://doi.org/10.1042/bj20041021

Article  CAS  PubMed Central  PubMed  Google Scholar 

Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P, Song Y, Tzima E, Kennerknecht E, Niepmann M, von Bruehl ML, Sedding D, Massberg S, Günther A, Engelmann B, Preissner KT (2007) Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 104(15):6388-6393.https://doi.org/10.1073/pnas.0608647104

Kravtsov DV, Matafonov A, Tucker EI, Sun MF, Walsh PN, Gruber A, Gailani D (2009) Factor XI contributes to thrombin generation in the absence of factor XII. Blood 114(2):452–458. https://doi.org/10.1182/blood-2009-02-203604

Article  CAS  PubMed Central  PubMed  Google Scholar 

Choi SH, Smith SA, Morrissey JH (2011) Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood 118(26):6963–6970. https://doi.org/10.1182/blood-2011-07-368811

Article  CAS  PubMed Central  PubMed  Google Scholar 

Pike GN, Cumming AM, Hay CR, Bolton-Maggs PH, Burthem J (2015) Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency. Blood 126(3):397–405. https://doi.org/10.1182/blood-2014-12-616565

Article  CAS  PubMed  Google Scholar 

Staritz P, de Moerloose P, Schutgens R, Dolan G (2013) Applicability of the European society of cardiology guidelines on management of acute coronary syndromes to people with haemophilia - an assessment by the ADVANCE working group. Haemophilia 19(6):833–840. https://doi.org/10.1111/hae.12189

Article  CAS  PubMed  Google Scholar 

Zucker M, Seligsohn U, Salomon O, Wolberg AS (2014) Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency. J Thromb Haemost 12(7):1121–1130. https://doi.org/10.1111/jth.12600

Article  CAS  PubMed Central  PubMed  Google Scholar 

Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP (2001) Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 86(4):959–972

CAS  PubMed  Google Scholar 

Maroney SA, Mast AE (2008) Expression of tissue factor pathway inhibitor by endothelial cells and platelets. Transfus Apher Sci 38(1):9–14. https://doi.org/10.1016/j.transci.2007.12.001

Article  PubMed Central